文献速递先天性心脏病外科心外重症与机械循环支持

儿童心脏移植术后早期机械循环支持:国际多中心分析

Mechanical circulatory support early after pediatric heart transplantation-an analysis from the Pediatric Heart Transplant Society.
PubMed 文献 · J Heart Lung Transplant · 2024-09-11

基于儿科心脏移植学会数据库2010-2020年4321例首次心脏移植的回顾性分析,249例(5.8%)在移植后30天内需要机械循环支持(MCS),其中230例为ECMO、19例为心室辅助装置。需要MCS者1年生存率为54.2%,显著低于不需要MCS者的94.8%(p<0.0001);但存活至1年的患者后期生存两组相似。

要点

  • 儿童心脏移植术后30天内MCS使用率为5.8%(249/4321),以ECMO为主(230例)。
  • 需要MCS者1年生存率54.2%,不需要MCS者94.8%(p<0.0001)。
  • 存活至1年的患者后期生存两组相似。

核心结论

  • 儿童心脏移植术后MCS使用不频繁,与供者、受者及移植因素相关;虽然死亡率高,但存活过移植后第一年的患者结局极好,因此对否则会死亡的患者合理使用MCS是合理的。

研究设计与样本

  • 国际前瞻性事件驱动数据库(儿科心脏移植学会数据库)的回顾性分析,纳入11年期间(2010-2020年)所有首次心脏移植病例,按移植后30天内是否需要MCS分组。

主要发现

  • 4321例首次心脏移植中249例(5.8%)需要MCS,包括230例ECMO和19例心室辅助装置。
  • Cox比例风险模型中,先天性心脏病(p=0.0002)、供者年龄较大(p<0.0001)和缺血时间较长(p=0.018)各自与MCS需求增加相关。
  • 受者体表面积增加(p<0.0001)和供者左心室射血分数增加(p=0.016)均与MCS使用减少相关。
  • 需要MCS者1年生存率为54.2%,不需要MCS者为94.8%(p<0.0001)。
  • 存活至1年的患者后期生存两组相似。

临床怎么用

  • 儿童心脏移植术后早期MCS使用不频繁,但对否则会死亡的患者合理使用MCS是合理的。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of early mechanical circulatory support (MCS) following pediatric heart transplantation is not well-published. This paper attempts to uncover the incidence, predisposing factors, and outcomes of MCS in a large, international cohort. METHODS: The Pediatric Heart Transplant Society Database (an international, prospective, event-driven database) was retrospectively analyzed for all cases of primary heart transplant over an 11-year period (2010-2020), dividing the cohort based on need for MCS within 30 days of transplantation. RESULTS: Of 4,321 primary transplants, 249 (5.8%) required MCS (230 ECMO (Extracoporeal Membranous Oxygenation), 19 ventricular assist device). In a Cox proportional hazard model, congenital heart disease (p = 0.0002), older donor age (p < 0.0001), and longer ischemic time (p = 0.018) were each related to an increased need for MCS; increasing recipient body surface area (p < 0.0001) and increasing donor left ventricular ejection fraction (p = 0.016) were both correlated with less MCS use. One-year survival in those requiring MCS was 54.2%, compared with 94.8% in those who did not need MCS (p < 0.0001). Later survival in patients surviving to 1 year was similar between the groups. CONCLUSIONS: MCS is used infrequently following pediatric heart transplant and is related to donor, recipient, and transplant factors. Although mortality is high, those surviving the first year post transplant have excellent outcomes. Judicious use in those patients who would otherwise perish is therefore justified.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Simmonds J, Zangwill SD, Wisotzkey B, et al. Mechanical circulatory support early after pediatric heart transplantation-an analysis from the Pediatric Heart Transplant Society. J Heart Lung Transplant. 2024. PMID: 39270993. doi:10.1016/j.healun.2024.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。